Use of liver stiffness measurement for HCC risk stratification in metabolic dysfunction–associated steatotic liver disease
LSM is associated with HCC risk in MASLD. HCC surveillance should be considered in noncirrhotic MASLD with diabetes and LSM of ≥10 kPa.
Authors
- Amit G. Singal (ORCID: https://orcid.org/0000-0002-1172-3971)
- Yangyang Deng (ORCID: https://orcid.org/0000-0001-9981-1425)
- Bassam Dahman (ORCID: https://orcid.org/0000-0001-7209-5369)
- Dustin Bastaich
- Binu V. John (ORCID: https://orcid.org/0000-0002-2002-9682)
Institutions
- Johns Hopkins University (US)
- University of Miami (US)
- Virginia Commonwealth University (US)
- Miami VA Healthcare System (US)
- Artistic Realization Technologies (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Hepatology
- Published
- 2025-08-14
- DOI
- https://doi.org/10.1097/hep.0000000000001498
- Citations
- 9
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 12.19